Furthermore, immunohistochemical analysis showed that hBsTE:hPBMC treatment yielded a higher infiltration of CD8+ T-cells into tumor tissues than hPBMC treatment alone (Fig. 6F, G). This evidence concerns the gene CD8A and neoplasm.